55513-164-01 |
55513-164 |
HUMAN PRESCRIPTION DRUG |
Kanjinti |
trastuzumab-anns |
KIT |
|
20230201 |
N/A |
BLA |
BLA761073 |
Amgen Inc |
|
|
1 KIT in 1 CARTON (55513-164-01) * 1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-01) / 20 mL in 1 VIAL, MULTI-DOSE * 20 mL in 1 VIAL (55513-152-01) |
55513-141-01 |
55513-141 |
HUMAN PRESCRIPTION DRUG |
Kanjinti |
trastuzumab-anns |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20191028 |
N/A |
BLA |
BLA761073 |
Amgen Inc |
TRASTUZUMAB |
150 mg/7.15mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (55513-141-01) / 7.15 mL in 1 VIAL, SINGLE-DOSE |
55513-132-01 |
55513-132 |
HUMAN PRESCRIPTION DRUG |
Kanjinti |
trastuzumab-anns |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20190611 |
N/A |
BLA |
BLA761073 |
Amgen Inc |
TRASTUZUMAB |
420 mg/20mL |
1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-01) / 20 mL in 1 VIAL, MULTI-DOSE |